EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30, 2025
EQS-Ad-hoc: VITRUVIA MEDICAL AG / Key word(s): Half Year Results/Half Year Report Werbung Werbung Vitruvia Medical AG half-year results as of June 30, 2025
Vitruvia Medical AG achieves results as expected in the first half of 2025. The Board of Directors confirms the forecast for the year as a whole. Vitruvia Medical AG is on target for the first six months of 2025. The result amounted to a slightly declining CHF -73’889.88 compared to CHF -53’388.06 in the previous year. Based on the expected results for the first half of 2025, the company's management confirms the outlook for the current full year. For this period, the Board of Directors expects consolidated sales of around EUR 2.4 million. On a consolidated basis, Vitruvia Medical AG anticipates a further improvement in earnings compared to the previous year.
End of Inside Information
01-Aug-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Werbung Werbung |
Language: | English |
Company: | Vitruvia Medical AG |
Kesselackerstr. 18 | |
5611 Anglikon | |
Switzerland | |
Phone: | +41 44 915 33 78 |
E-mail: | kontakt@vitruvia-med.com |
Internet: | www.vitruvia-med.com |
ISIN: | CH0461931419 |
WKN: | A2PDWF |
Listed: | Regulated Unofficial Market in Munich |
EQS News ID: | 2178096 |
End of Announcement | EQS News Service |
|
2178096 01-Aug-2025 CET/CEST
Nachrichten zu VITRUVIA MEDICAL AG
Analysen zu VITRUVIA MEDICAL AG
Keine Analysen gefunden.